AVANOS MEDICAL, INC. (AVNS) research

AVANOS MEDICAL, INC.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Devices
Last price
$24.99
As of

AVANOS MEDICAL, INC. (AVNS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-30.

As of . Source: SEC EDGAR filings for AVNS. Method and limitations.

SHARE THIS CARD

Share the AVNS intelligence card

A branded snapshot of AVNS: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion AVNS intelligence card preview
Post to X
LIVE TERMINAL

See AVNS live in the terminal

Track AVNS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live AVNS terminal, free

Active signals for AVNS

FREE, NO ACCOUNT

Every signal on AVNS, as it fires

You are seeing 5 of 19 signals recorded on AVNS since 2026-05-26.

The five above all landed on 2026-09-06. The other 14 were recorded on 4 other days. 13 of the 19 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in AVNS (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 05350V106 · 2026Q2$37.9M0.01%,
D. E. Shaw & Co., Inc.CUSIP 05350V106 · 2026Q2$7M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 05350V106 · 2026Q2$6.4M0.01%,
TWO SIGMA INVESTMENTS, LPCUSIP 05350V106 · 2026Q2$1.2M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, AVNS

AVNS against its peers

AVNS's operating margin of -8.8% ranks in the 64th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.

MetricAVNSPeer medianPercentilen
Revenue FY701M USD218M USD7920
Gross margin50.5%66.9%2918
Operating margin-8.8%-17.5%6420
Net margin-10.4%-19.1%5520
Return on equity-9.4%-18.8%6420
P / En/a31.9xn/a5

Peers (20): IART, BBNX, AORT, ENOV, CBLL, INMD, SIBN, QDEL, BFLY, SSII, ESTA, UFPT, KIDS, DCTH, AXGN, SENS, TCMD, NPCE, NEOG, MASS. Left out: LMRI (no annual filing), NHNKF (no annual filing), OSSUY (no annual filing), ALMR (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (AVNS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more AVNS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to AVNSand get the insider, 13F, options, and confluence read in one view.

Open the live AVNS terminal, free